427 Effectiveness of Cholecystectomy to Prevent Recurrent Acute Biliary Pancreatitis

Kamal, Ayesha; Akshintala, Venkata S.; Kazzi, Elie S. Al; Singh, Vikesh K.; Kalloo, Anthony N.; Hutfless, Susan

doi:10.1016/j.gie.2015.03.1224

Cited by 2 publications

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In an audit of 76 188 patients admitted for ABP, only 11.1% underwent cholecystectomy within the 4‐week period. Four percent never underwent cholecystectomy, 0.4% had cholecystectomy after 4 weeks but within 1 year of the initial hospitalization and 83% had a cholecystectomy more than 1 year after initial hospitalization . Of those patients who underwent cholecystectomy within 4 weeks of ABP, 3.4% were hospitalized for recurrent pancreatitis compared to a 9% admission rate for pancreatitis in patients who did not undergo cholecystectomy within the recommended period ( P < 0.001).…”

Section: Clinical Practice Of Ercpmentioning

confidence: 95%

“…The above four studies related to ERCP convey strong messages. Adherence to guidelines that recommend cholecystectomy within 4 weeks of ABP is important as it avoids unnecessary hospitalization related to underlying disease . Refractory bleeding after sphincterotomy can be managed successfully by fibrin glue injection, and interventional radiology‐guided coil embolization is not the only available rescue technique .…”

Section: Editorial Commentsmentioning

confidence: 99%

See 1 more Smart Citation

Digestive Disease Week (DDW) 2015: Pancreaticobiliary update

Varadarajulu

Bang

2015

Digestive Endoscopy

View full text Add to dashboard Cite

This update critiques the key abstracts relevant to endoscopic evaluation or interventions in pancreatic and biliary diseases that were presented at Digestive Disease Week (DDW) 2015. We selected 20 abstracts based on their clinical significance, relevance to endoscopic practice and impact on patient management Key words: biliary drainage, endoscopic retrograde cholangio pancreatography (ERCP), endoscopic ultrasonography (EUS), interventional EUS, pancreatic cysts EVALUATION AND TREATMENT OF PANCRE-ATIC CYST LESIONS S EVERAL ABSTRACTS WERE presented on the endoscopic evaluation and treatment of pancreatic cyst lesions. In a retrospective study of 321 patients with pancreatic cyst lesions who were followed for a mean duration of 31 months, only 10 patients were referred for surgery.1 In eight of 10 patients, the presumed diagnosis was found to be correct at surgery and no disease progression was found in any patient at follow up.In another study of 535 asymptomatic high-risk patients with intraductal papillary mucinous neoplasm (IPMN) who either had pancreatic cysts >5 mm or dilated main pancreatic duct >2.5 mm in diameter, surveillance was undertaken using pancreatic protocol ultrasound every 3 months, computed tomography (CT) or magnetic resonance imaging (MRI) every 12 months, and then endoscopic ultrasonography (EUS) if there were changes in the size of the cyst or duct morphology. 2 Thirteen (2.4%) cases of IPMN with malignancy were confirmed over a median follow-up duration of 34 months and seven of these 13 patients had multiple cysts <2 cm in size. The authors observed that cyst size alone may not be a major determinant in predicting cancer risk; multiple small cysts may be another feature that is predictive of progression to malignancy.A retrospective study of 364 patients with branch-duct (BD) IPMN attempted to identify predictors of malignancy and recurrence at long-term follow up.3 In this study, 135 of 364 patients underwent surgical resection and 229 underwent imaging surveillance. Among patients who underwent surgery, the presence of main pancreatic duct (MPD) dilation (5-9 mm) was more frequently associated with malignant lesions (P = 0.01). Following surgery, patients with malignant BD-IPMN had higher tumor recurrence rates (17 vs 7%, P = 0.03). Moreover, EUS features such as mural nodules, suspicious MPD (thick walls, mucin or mural nodule), suspicious or malignant cytology and MPD size of 5-9 mm on CT/MRI were strongly associated with malignant BD-IPMN. The accuracy of cytology, carcinoembryonic antigen (CEA) and amylase were evaluated in a cohort of 1167 patients with IPMN who underwent EUS-guided fine-needle aspiration (EUS-FNA).4 Sensitivity, specificity and accuracy of cytology for differentiating benign from malignant IPMN were 39%, 88% and 64%, respectively. At a cut-off value of 129 ng/mL, the sensitivity and specificity of CEA was only 76.9% and 83.3%, respectively, and cyst amylase analysis was diagnostically unhelpful.A retrospective study compared the clinical outcomes of pancreatic ...

show abstract

Section: Clinical Practice Of Ercpmentioning

confidence: 95%

Section: Editorial Commentsmentioning

confidence: 99%

Digestive Disease Week (DDW) 2015: Pancreaticobiliary update

Varadarajulu

Bang

2015

Digestive Endoscopy

View full text Add to dashboard Cite

show abstract

Effectiveness of Guideline-Recommended Cholecystectomy to Prevent Recurrent Pancreatitis

Kamal

Akhuemonkhan

Akshintala

et al. 2017

American Journal of Gastroenterology

View full text Add to dashboard Cite

Nearly four out of five patients underwent cholecystectomy for acute biliary pancreatitis in a timeframe, consistent with guidelines. Adherence resulted in a decrease in subsequent hospitalizations for both acute and chronic pancreatitis. However, the majority of non-adherent patients did not undergo a subsequent cholecystectomy. There may be factors that predict the need for immediate vs. delayed cholecystectomy.

show abstract

427 Effectiveness of Cholecystectomy to Prevent Recurrent Acute Biliary Pancreatitis

Cited by 2 publications

References 0 publications

Digestive Disease Week (DDW) 2015: Pancreaticobiliary update

Digestive Disease Week (DDW) 2015: Pancreaticobiliary update

Effectiveness of Guideline-Recommended Cholecystectomy to Prevent Recurrent Pancreatitis

Contact Info

Product

Resources

About